SENSOREADY
Live / Applied — First extension granted (statement of use) (as of 13 Feb 2026)
What this means for you
Not registered yet, but its 08 May 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99175308
- Mark type
- Stylized text
- Filed
- 08 May 2025
- Published for opposition
- 01 Jul 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Autoinjectors sold pre-filled with pharmaceutical preparations for the prevention and treatment of disorders and diseases of the immune system; pharmaceutical preparations for the prevention and treatment of musculoskeletal disorders; pharmaceutical preparations for use in dermatology, rheumatology, oncology, and hematology
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 14 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2026 — SOU EXTENSION 1 GRANTED
- 13 Feb 2026 — SOU EXTENSION 1 FILED
- 13 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jul 2025 — PUBLISHED FOR OPPOSITION
- 25 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 May 2025 — ASSIGNED TO EXAMINER
- 08 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 08 May 2025 — APPLICATION FILING RECEIPT MAILED
- 08 May 2025 — NEW APPLICATION ENTERED